Investigation of CBS, MTR, RFC-1 and TC polymorphisms as maternal risk factors for Down syndrome
20 mg/2.4 mL (5 mg dose)
Before enrolling, confirm the specific medical entity and provider assigned to your case, the dispensing pharmacy, your complete price, and your prescription details directly with JoinSkinny - rather than relying on marketing claims alone
The 21 cases involve GLP-1 users who suffered permanent vision loss after taking the medications
The topic of the current review is the molecular regulation of autophagy by glucagon, glucagon-like peptide (GLP)-1 and the GLP-1-degrading enzyme dipeptidyl peptidase-4 (DPP-4)
"The use of these drugs has exploded throughout industrialized countries and they have provided very significant benefits in many ways, but future discussions between a patient and their physician should include NAION as a potential risk," said lead researcher Dr